12th Annual Sentinel Initiative Public Workshop

Event

12th Annual Sentinel Initiative Public Workshop

Register
October 14, 2020 — 1:00PM–4:00PM

Virtual

Contact Information

Margolis Events

margolisevents@duke.edu

The Sentinel Initiative, an active medical product surveillance system, was established in response to the Food and Drug Administration (FDA) Amendments Act of 2007 and has become one of the Agency’s premier evidence generation platforms. The 12th Annual Sentinel Initiative Public Workshop is being convened on October 14, 2020 by the Robert J. Margolis, MD, Center for Health Policy under a cooperative agreement with the FDA. The workshop will be held as a virtual webinar and provides an opportunity to discuss recent achievements and developments and engage with the broader community of patients, consumers, and scientific stakeholders.

This year’s meeting will feature a keynote by FDA’s Dr. Patrizia Cavazzoni as well as presentations from numerous expert panelists who will provide updates on key Sentinel Initiative developments, milestones, and strategic aims. Discussion will also consider recent activities and applications of the Sentinel Initiative as part of the U.S. FDA’s efforts to protect and promote public health during the COVID-19 pandemic.

MEETING AGENDA AND MATERIALS

The agenda, speaker bios, and meeting materials will be available on the Duke-Margolis Center for Health Policy event page.

REGISTRATION

Please register above for listen-only access to the virtual workshop. Registrants will be encouraged to submit questions during the meeting, and meeting moderators will work them into the Q & A discussion.

If you have any questions or concerns, please email margolisevents@duke.edu.

 

Funding for this conference was made possible by a cooperative agreement from the Food and Drug Administration, Center for Drug Evaluation Research. The views expressed in written conference materials and the speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsements by the U.S. Government.